A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.
Manegold C, van Zandwijk N, Szczesna A, Zatloukal P, Au JSK, Blasinska-Morawiec M, Serwatowski P, Krzakowski M, Jassem J, Tan EH, Benner RJ, Ingrosso A, Meech SJ, Readett D, Thatcher N.
Manegold C, et al. Among authors: zatloukal p.
Ann Oncol. 2012 Jan;23(1):72-77. doi: 10.1093/annonc/mdr030. Epub 2011 Apr 4.
Ann Oncol. 2012.
PMID: 21464154
Free article.
Clinical Trial.